DGAP-Adhoc: Fresenius SE: Fresenius announces Senior Notes

Fresenius SE / Issue of Debt/Forecast

12.01.2009 

Release of a Adhoc News, transmitted by DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------

Fresenius announces Senior Notes Offering 

Fresenius today announced its intention to issue Senior Unsecured Notes
through its subsidiary Fresenius U.S. Finance II, Inc., subject to market
conditions. The offering will comprise separate euro and US dollar
tranches. The Notes are expected to have a maturity of 6 years or more.

Proceeds of the Notes offering will be used to further repay the bridge
loan used to finance the acquisition of APP Pharmaceuticals. This bridge
loan currently amounts to US$ 650 million, half of the initial drawing of
US$ 1,300 million in September 2008. The other components of the
acquisition financing have already been successfully completed: Senior
Secured Credit Facilities including US$ 2,500 million term loans and US$
550 million revolving facilities, a  289 million equity issue and a  554
million Mandatory Exchangeable Bond.

The Notes are being offered in private placements and there will be no
public offering of the Notes.

Fresenius confirms its outlook for 2008. Group sales were expected to grow
by 9.5 to 10.5 % and net income by 10 to 15 %, both in constant currency.
This outlook excludes the APP acquisition and related special items.

Fresenius also provides a preview on its expectations for 2009. Group
organic sales growth is expected to be at least in the mid single-digit
range. Net income growth in constant currency and before special items
related to the APP acquisition is expected to be greater than organic sales
growth. A detailed outlook will be provided as part of the 2008 earnings
release expected to be issued on February 19, 2009.

The Management Board

Bad Homburg v.d.H., January, 12 2009
End of note
DGAP 12.01.2009 
---------------------------------------------------------------------------
Language:     English
Issuer:       Fresenius SE
              Else-Kröner-Straße 1
              61352 Bad Homburg v.d.H.
              Deutschland
Phone:        +49 (0)6172 608-2485
Fax:          +49 (0)6172 608-2488
E-mail:       ir-fre@fresenius.com
Internet:     www.fresenius.com
ISIN:         DE0005785638, DE0005785604
WKN:          578563, 578560
Indices:      MDAX
Listed:       Regulierter Markt in Frankfurt (Prime Standard), Düsseldorf,
              München; Freiverkehr in Berlin, Hannover, Stuttgart, Hamburg;
              Terminbörse EUREX
End of News                                     DGAP News-Service
---------------------------------------------------------------------------
DGAP-Adhoc: Fresenius SE: Fresenius announces Senior Notes Offering
